Biohaven Pharmaceutical Holding Co Ltd(BHVN:US)
Market Cap$1.622B
Key Metrics
Price$10.78
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$647.68M
EBITDA (TTM)-$644.2M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$273.07M
Total Assets$466.41M
Net Assets$129.5M
Total Debt$286.18M
Key Metrics
Price$10.78
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$647.68M
EBITDA (TTM)-$644.2M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$273.07M
Total Assets$466.41M
Net Assets$129.5M
Total Debt$286.18M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $130.43M | $142.73M | $169.38M | $211.7M | $221.56M | $189.93M | $178.17M | $333.77M | $183.24M | $153.71M | $110.55M | $94.01M | $77.78M | $213.41M | $67.64M | $197.11M | $89.77M | $50.88M | $55.49M | |
| Research and Development | $103.83M | $121.95M | $141.17M | $184.37M | $187.58M | $167.47M | $157.61M | $314.82M | $155.97M | $134.81M | $95.52M | $79.49M | $63.46M | $137.04M | $52.85M | $177.09M | $70.1M | $41.82M | $46.97M |
| Selling, General, and Administrative | $26.6M | $20.79M | $28.21M | $27.33M | $33.98M | $22.46M | $20.56M | $18.95M | $27.27M | $18.9M | $15.03M | $14.52M | $14.32M | $76.37M | $14.79M | $20.02M | $19.68M | $9.07M | $8.52M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$130.43M | -$142.73M | -$169.38M | -$211.7M | -$221.56M | -$189.93M | -$178.17M | -$333.77M | -$183.24M | -$153.71M | -$110.55M | -$94.01M | -$77.78M | -$213.41M | -$67.64M | -$197.11M | -$89.77M | -$50.88M | -$55.49M |
| $168K | -$2.47M | -$3.84M | $13.82M | $493K | $3.14M | $17.81M | $14.18M | $4.31M | $7.74M | $4.69M | $5.84M | $8.23M | -$1.84M | - | -$67K | -$4K | $1.45M | -$5K | |
| Non-Operating Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | $168K | -$2.47M | -$3.84M | $13.82M | $493K | $3.14M | $17.81M | $14.18M | $4.31M | $7.74M | $4.69M | $5.84M | $8.23M | -$1.84M | - | -$67K | -$4K | $1.45M | -$5K |
Income Before Tax | -$130.26M | -$145.2M | -$173.22M | -$197.89M | -$221.07M | -$186.8M | -$160.36M | -$319.59M | -$178.94M | -$145.97M | -$105.86M | -$88.17M | -$69.55M | -$215.25M | -$67.64M | -$197.18M | -$89.78M | -$49.43M | -$55.5M |
Income Tax | $272K | $351K | $221K | $261K | $609K | $48K | -$59K | $177K | $569K | -$1.21M | -$3.29M | $2.18M | $939K | -$14.14M | $1.22M | $6.11M | $7.26M | $2.46M | -$1.13M |
Net Income | -$130.53M | -$145.56M | -$173.44M | -$198.15M | -$221.68M | -$186.84M | -$160.3M | -$319.77M | -$179.5M | -$144.76M | -$102.57M | -$90.35M | -$70.49M | -$201.11M | -$68.85M | -$203.29M | -$97.03M | -$51.89M | -$54.37M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$130.53M | -$145.56M | -$173.44M | -$198.15M | -$221.68M | -$186.84M | -$160.3M | -$319.77M | -$179.5M | -$144.76M | -$102.57M | -$90.35M | -$70.49M | -$201.11M | -$68.85M | -$203.29M | -$97.03M | -$51.89M | -$54.37M |
Shares Outstanding (Basic) | 147.62M | 120.19M | 105.82M | 102.37M | 101.94M | 101.05M | 94.37M | 87.77M | 81.6M | - | 68.32M | 68.25M | 68.21M | - | 39.38M | 35.82M | 35.82M | - | 35.82M |
Shares Outstanding (Diluted) | 147.62M | 120.19M | 105.82M | 102.37M | 101.94M | 101.05M | 94.37M | 87.77M | 81.6M | - | 68.32M | 68.25M | 68.21M | - | 39.38M | 35.82M | 35.82M | - | 35.82M |
EPS (Basic) | -$0.88 | -$1.21 | -$1.64 | -$1.94 | -$2.17 | -$1.85 | -$1.70 | -$3.64 | -$2.20 | - | -$1.50 | -$1.32 | -$1.03 | - | -$1.75 | -$5.67 | -$2.71 | - | -$1.52 |
EPS (Diluted) | -$0.88 | -$1.21 | -$1.64 | -$1.94 | -$2.17 | -$1.85 | -$1.70 | -$3.64 | -$2.20 | - | -$1.50 | -$1.32 | -$1.03 | - | -$1.75 | -$5.67 | -$2.71 | - | -$1.52 |
EBIT | -$130.43M | -$142.73M | -$169.38M | -$211.7M | -$221.56M | -$189.93M | -$178.17M | -$333.77M | -$183.24M | -$153.71M | -$110.55M | -$94.01M | -$77.78M | -$213.41M | -$67.64M | -$197.11M | -$89.77M | -$50.88M | -$55.49M |
EBITDA | -$128.06M | -$140.16M | -$166.26M | -$209.72M | -$219.32M | -$187.47M | -$176.17M | -$331.82M | -$181.79M | -$151.82M | -$109.01M | -$92.18M | -$76.13M | -$213.07M | -$67.26M | -$196.7M | -$89.52M | -$50.2M | -$55.27M |